ScreenerHero

OVAT Ovation Science Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · ovationscience.com
0.0300CAD0.00%Mkt Cap: 839867 $P/E: —

Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States. The company's patented skin delivery technology Invisicare, a patented polymer-based technology f…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap839.87K USD
Enterprise Value1.04M USD
Revenue (TTM)41.76K USD
Gross Profit42.29K USD
Net Income (TTM)-459.72K USD
Revenue/Share0.0020 CAD
Last Price0.0300 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA69016D1087
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue24.98
P/S20.11
P/B-0.64
EPS (TTM)-0.02
EPS (Forward)—
52W Range
0.015043% of range0.0500
52W High0.0500 CAD
52W Low0.0150 CAD
Profitability
Gross Margin85.53%
Oper. Margin-2041.44%
EBITDA Margin0.00%
Profit Margin-929.86%
ROE43.26%
ROA-762.22%
Growth
Revenue Growth-50.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-55.67K USD
CapEx (TTM)—
FCF Margin241.13%
FCF Yield11.99%
Net Debt203.13K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.19
Current Ratio0.01
Quick Ratio0.01
Book Value/Sh-0.05 CAD
Cash/Share0.00 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.38.44M
Float33.25M
Insiders23.45%
Institutions0.00%
Short Interest
Short Ratio1.8d
Short % Out.0.00%
Shares Short299
Short (prev mo.)1.01K
Technical
SMA 500.0284 (+5.6%)
SMA 2000.0278 (+7.8%)
Beta0.58
S&P 52W Chg16.45%
Avg Vol (30d)1.69K
Avg Vol (10d)0
Technical Indicators
RSI (14)67.1
MACD0.0023
MACD Signal0.0026
MACD Hist.-0.0003
BB Upper0.0352 CAD
BB Middle0.0290 CAD
BB Lower0.0228 CAD
BB Width42.45%
ATR (14)0.0007 CAD
Vol Ratio (20d)0.00x